Morbidity and Mortality Weekly Report (MMWR)
The Morbidity and Mortality Weekly Report (MMWR) series are CDC’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. The MMWR series includes the following publications: MMWR Weekly, MMWR Recommendations and Reports, CDC Surveillance Summaries and MMWR Supplements. These journals are freely available to the public as Diamond Open Access. For more on MMWR, visit https://www.cdc.gov/mmwr/index.html.
Select all docs (Max 200)
Narrow Results:
Volume
Series
Publication Year
Medical Subject
- 2019-nCoV Vaccine mRNA-1273 2
- 2019-nCoV Vaccine MRNA-1273 1
- Academic Medical Centers 2
- Adolescent 6
- Adult 11
- Aged 6
- Ambulatory Care 1
- Ambulatory Care Facilities 2
- Antibodies, Viral 2
- Antibodies, Viral/blood 1
- Asymptomatic Diseases 1
- BetacoronaVirus 3
- BNT162 Vaccine 3
- Case-Control Studies 1
- Communicable Disease Control 1
- Community-Acquired Infections 1
- Contact Tracing 1
- CoronaVirus Infections 10
- CoronaVirus Infections/Diagnosis 1
- CoronaVirus Infections/Prevention & Control 2
- Coronavirus Infections/prevention & control 1
- CoronaVirus Infections/Prevention & cotrol 1
- COVID-19 16
- COVID-19 Serological Testing 1
- COVID-19 Vaccines 9
- COVID-19/Prevention & Control 2
- COVID-19/Prevention & cotrol 1
- Cross Infection 1
- Delivery of Health Care 1
- Environmental Exposure 1
- Female 10
- Full Report 5
- Health Personnel 1
- Hospitalization 9
- Hospital Mortality 1
- Hospitals, University 1
- Humans 15
- Immunization, Secondary 1
- Immunocompetence 1
- Immunocompromised Host 2
- Infectious Disease Transmission, Professional-to-Patient 1
- Inpatients 1
- Male 10
- Middle Aged 9
- mRNA Vaccines 1
- Outpatients 1
- Pandemics 7
- Pandemics/prevention & control 1
- Patient Safety 1
- Personal Protective Equipment 1
- Personnel, Hospital 2
- Pneumonia, Viral 7
- Pneumonia, Viral/Diagnosis 1
- Pneumonia, Viral/prevention & control 1
- Prevalence 1
- Recovery of Function 1
- Respiration, Artificial 2
- Risk Assessment 1
- Risk Factors 2
- RNA, Messenger 2
- SARS-CoV-2 5
- Seroepidemiologic Studies 2
- Serologic Tests 1
- Social Distance 1
- Socioeconomic Factors 1
- Symptom Assessment 2
- Telecommunications 1
- Time Factors 2
- Treatment Outcome 3
- United States 1
- Vaccination 4
- Vaccination Coverage 1
- Vaccine Efficacy 4
- Vaccines, Combined 2
- Vaccines, Synthetic 3
- Viral Vaccine 1
- Viral Vaccines 1
- Work 1
- Young Adult 5
Personal Author
- Files, D. Clark (20)
Corporate Author
- Baylor Scott & White Health. 4
- Baystate Medical Center, Springfield, Massachusetts 2
- Baystate Medical Center, Springfield, Massachusetts. 2
- Baystate Medical Center. 3
- Beth Israel Deaconess Medical Center. 5
- CDC COVID-19 Emergency Response Team. 1
- CDC COVID-19 Response Team 6
- CDC COVID-19 Response Team. 4
- CDC COVID- Response Team. 2
- Cleveland Clinic. 2
- Emory University School of Medicine. 2
- HAIVEN Investigators 1
- Harborview Medical Center (Seattle, Wash.) 1
- Hennepin County Medical Center. 7
- Hospitalized Adult Influenza Vaccine Effectiveness Network. 1
- Intermountain Health Care (Utah) 1
- Intermountain Medical Center (Utah) 1
- Intermountain Medical Center. 1
- Intermountain Medical Center and University of Utah, Salt Lake City, Utah 1
- Intermountain Medical Center and University of Utah. 1
- IVY Network 9
- IVY Network. 4
- IVY Network Investigators 4
- IVY Network Investigators. 2
- Johns Hopkins Hospital. 5
- Montefiore Healthcare Center. 1
- Montefiore Medical Center. 1
- Montefiore Medical Center and Albert Einstein College of Medicine. 5
- Oak Ridge Institute for Science and Education. 1
- Ohio State University. Wexner Medical Center. 4
- Ohio State University Wexner Medical Center. 2
- Oregon Health & Sciences University. 1
- Oregon Health & Sciences University Hospital. 1
- Oregon Health & Science University Hospital. 3
- Ronald Reagan-UCLA Medical Center. 3
- St. Joseph Mercy Health System (Ann Arbor, Michigan) 1
- Stanford University. School of Medicine. 1
- Stanford University Medical Center. 3
- Stanford University School of Medicine. 1
- Texas A&M University. College of Medicine. 2
- Texas A&M University College of Medicine. 2
- UCLA Medical Center, Los Angeles, California. 1
- UCLA Medical Center. 1
- University of Colorado School of Medicine (Aurora) 2
- University of Colorado School of Medicine, Aurora, Colorado 3
- University of Iowa. 3
- University of Miami. 2
- University of Michigan, School of Public Health. 1
- University of Michigan. School of Medicine. 1
- University of Michigan School of Medicine. 1
- University of Michigan School of Public Health. 3
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. 1
- University of Utah. 1
- University of Washington Medical Center,. 1
- University of Washington Medical Center. 1
- University of Washington School of Medicine. 3
- Vanderbilt University Medical Center,. 1
- Vanderbilt University Medical Center, Nashville, Tennessee. 1
- Vanderbilt University Medical Center. 5
- Wake Forest University. Baptist Medical Center. 2
- Wake Forest University Baptist Medical Center. 5
- Washington University. 2
Place as Subject
- Alabama 1
- Arizona 1
- California 2
- Colorado 3
- Florida 1
- Georgia 1
- Germanu 1
- Indiana 1
- Iowa 1
- Los Angeles, CA 1
- Louisiana 1
- Maryland 3
- Massachusetts 2
- Michigan 1
- Minnesota 3
- Missouri 1
- New Mexico 1
- New York 2
- New York City, NY 1
- North Carolina 3
- Ohio 2
- Oregon 2
- Seattle, WA 1
- Tennessee 2
- Texas 1
- United States 15
- Utah 3
- Washington 2
Resource Type General
x
Files, D. Clark
Select all docs
(Max 200)
(Max 200)
1 -
20 of 20 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- 2019-nCoV Vaccine mRNA-1273 (2)
- 2019-nCoV Vaccine MRNA-1273 (1)
- Academic Medical Centers (2)
- Adolescent (6)
- Adult (11)
- Aged (6)
- Ambulatory Care (1)
- Ambulatory Care Facilities (2)
- Antibodies, Viral (2)
- Antibodies, Viral/blood (1)
- Asymptomatic Diseases (1)
- BetacoronaVirus (3)
- BNT162 Vaccine (3)
- Case-Control Studies (1)
- Communicable Disease Control (1)
- Community-Acquired Infections (1)
- Contact Tracing (1)
- CoronaVirus Infections (10)
- CoronaVirus Infections/Diagnosis (1)
- CoronaVirus Infections/Prevention & Control (2)
- Coronavirus Infections/prevention & control (1)
- CoronaVirus Infections/Prevention & cotrol (1)
- COVID-19 (16)
- COVID-19 Serological Testing (1)
- COVID-19 Vaccines (9)
- COVID-19/Prevention & Control (2)
- COVID-19/Prevention & cotrol (1)
- Cross Infection (1)
- Delivery of Health Care (1)
- Environmental Exposure (1)
- Female (10)
- Full Report (5)
- Health Personnel (1)
- Hospitalization (9)
- Hospital Mortality (1)
- Hospitals, University (1)
- Humans (15)
- Immunization, Secondary (1)
- Immunocompetence (1)
- Immunocompromised Host (2)
- Infectious Disease Transmission, Professional-to-Patient (1)
- Inpatients (1)
- Male (10)
- Middle Aged (9)
- mRNA Vaccines (1)
- Outpatients (1)
- Pandemics (7)
- Pandemics/prevention & control (1)
- Patient Safety (1)
- Personal Protective Equipment (1)
- Personnel, Hospital (2)
- Pneumonia, Viral (7)
- Pneumonia, Viral/Diagnosis (1)
- Pneumonia, Viral/prevention & control (1)
- Prevalence (1)
- Recovery of Function (1)
- Respiration, Artificial (2)
- Risk Assessment (1)
- Risk Factors (2)
- RNA, Messenger (2)
- SARS-CoV-2 (5)
- Seroepidemiologic Studies (2)
- Serologic Tests (1)
- Social Distance (1)
- Socioeconomic Factors (1)
- Symptom Assessment (2)
- Telecommunications (1)
- Time Factors (2)
- Treatment Outcome (3)
- United States (1)
- Vaccination (4)
- Vaccination Coverage (1)
- Vaccine Efficacy (4)
- Vaccines, Combined (2)
- Vaccines, Synthetic (3)
- Viral Vaccine (1)
- Viral Vaccines (1)
- Work (1)
- Young Adult (5)
- Baylor Scott & White Health. (4)
- Baystate Medical Center, Springfield, Massachusetts (2)
- Baystate Medical Center, Springfield, Massachusetts. (2)
- Baystate Medical Center. (3)
- Beth Israel Deaconess Medical Center. (5)
- CDC COVID-19 Emergency Response Team. (1)
- CDC COVID-19 Response Team (6)
- CDC COVID-19 Response Team. (4)
- CDC COVID- Response Team. (2)
- Cleveland Clinic. (2)
- Emory University School of Medicine. (2)
- HAIVEN Investigators (1)
- Harborview Medical Center (Seattle, Wash.) (1)
- Hennepin County Medical Center. (7)
- Hospitalized Adult Influenza Vaccine Effectiveness Network. (1)
- Intermountain Health Care (Utah) (1)
- Intermountain Medical Center (Utah) (1)
- Intermountain Medical Center. (1)
- Intermountain Medical Center and University of Utah, Salt Lake City, Utah (1)
- Intermountain Medical Center and University of Utah. (1)
- IVY Network (9)
- IVY Network. (4)
- IVY Network Investigators (4)
- IVY Network Investigators. (2)
- Johns Hopkins Hospital. (5)
- Montefiore Healthcare Center. (1)
- Montefiore Medical Center. (1)
- Montefiore Medical Center and Albert Einstein College of Medicine. (5)
- Oak Ridge Institute for Science and Education. (1)
- Ohio State University. Wexner Medical Center. (4)
- Ohio State University Wexner Medical Center. (2)
- Oregon Health & Sciences University. (1)
- Oregon Health & Sciences University Hospital. (1)
- Oregon Health & Science University Hospital. (3)
- Ronald Reagan-UCLA Medical Center. (3)
- St. Joseph Mercy Health System (Ann Arbor, Michigan) (1)
- Stanford University. School of Medicine. (1)
- Stanford University Medical Center. (3)
- Stanford University School of Medicine. (1)
- Texas A&M University. College of Medicine. (2)
- Texas A&M University College of Medicine. (2)
- UCLA Medical Center, Los Angeles, California. (1)
- UCLA Medical Center. (1)
- University of Colorado School of Medicine (Aurora) (2)
- University of Colorado School of Medicine, Aurora, Colorado (3)
- University of Iowa. (3)
- University of Miami. (2)
- University of Michigan, School of Public Health. (1)
- University of Michigan. School of Medicine. (1)
- University of Michigan School of Medicine. (1)
- University of Michigan School of Public Health. (3)
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. (1)
- University of Utah. (1)
- University of Washington Medical Center,. (1)
- University of Washington Medical Center. (1)
- University of Washington School of Medicine. (3)
- Vanderbilt University Medical Center,. (1)
- Vanderbilt University Medical Center, Nashville, Tennessee. (1)
- Vanderbilt University Medical Center. (5)
- Wake Forest University. Baptist Medical Center. (2)
- Wake Forest University Baptist Medical Center. (5)
- Washington University. (2)
- Alabama (1)
- Arizona (1)
- California (2)
- Colorado (3)
- Florida (1)
- Georgia (1)
- Germanu (1)
- Indiana (1)
- Iowa (1)
- Los Angeles, CA (1)
- Louisiana (1)
- Maryland (3)
- Massachusetts (2)
- Michigan (1)
- Minnesota (3)
- Missouri (1)
- New Mexico (1)
- New York (2)
- New York City, NY (1)
- North Carolina (3)
- Ohio (2)
- Oregon (2)
- Seattle, WA (1)
- Tennessee (2)
- Texas (1)
- United States (15)
- Utah (3)
- Washington (2)
- :Tenforde, Mark W. ;Rose, Erica BilligJune 30, 2020 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):What is already known about this topic?: Exposures to SARS-CoV-2 have commonly been described in congregate settings rather than broader community set...
- :Tenforde, Mark W. ;Kim, Sara S.July 24, 2020 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):What is already known about this topic? Relatively little is known about the clinical course of COVID-19 and return to baseline health for persons wit...
- :Self, Wesley H. ;Tenforde, Mark W.August 31, 2020 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):What is already known about this topic? Little is known about the prevalence and features of SARS-CoV-2 infection among frontline U.S. health care per...
- :Tenforde, Mark W. ;Billig Rose, EricaJuly 03 2020 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):Descriptions of coronaVirus disease 2019 (COVID-19) in the United States have focused primarily on hospitalized patients. Reports documenting exposure...
- :Tenforde, Mark W. ;Kim, Sara S.July 31 2020 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):Prolonged symptom duration and disability are common in adults hospitalized with severe coronaVirus disease 2019 (COVID-19). Characterizing return to ...
- :Self, Wesley H. ;Tenforde, Mark W.September 04 2020 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):Health care personnel (HCP) caring for patients with coronaVirus disease 2019 (COVID-19) might be at high risk for contracting SARS-CoV-2, the Virus t...
- :Fisher, Kiva A. ;Tenforde, Mark W.September 11 2020 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):Community and close contact exposures continue to drive the coronaVirus disease 2019 (COVID-19) pandemic. CDC and other public health authorities reco...
- :Fisher, Kiva A. ;Olson, Samantha M.November 06 2020 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):Since March 2020, large-scale efforts to reduce Transmission of SARS-CoV-2, the Virus that causes coronaVirus disease 2019 (COVID-19), have continued....
- :Self, Wesley H. ;Tenforde, Mark W.November 27 2020 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):Most persons infected with SARS-CoV-2, the Virus that causes coronaVirus disease 2019 (COVID-19), develop Virus-specific antibodies within several wee...
- :Tenforde, Mark W. ;Olson, Samantha M.April 28, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):What is already known about this topic? Clinical trials suggest high efficacy for COVID-19 vaccines, but evaluation of vaccine effectiveness against s...
- :Self, Wesley H. ;Tenforde, Mark W.September 17, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):What is already known about this topic? Two 2-dose mRNA COVID-19 vaccines (from Pfizer-BioNTech and Moderna) and a 1-dose viral vector vaccine (from J...
- :Tenforde, Mark W. ;Self, Wesley H.August 18, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):What is already known about this topic? COVID-19 mRNA vaccines provide strong protection against severe COVID-19; however, the duration of protection ...
- :Tenforde, Mark W. ;Olson, Samantha M.5 07 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):Adults aged ≥65 years are at increased risk for severe outcomes from COVID-19 and were identified as a priority group to receive the first COVID-19 ...
- :Tenforde, Mark W. ;Self, Wesley H.8 27 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):Real-world evaluations have demonstrated high effectiveness of vaccines against COVID-19-associated hospitalizations (1-4) measured shortly after vacc...
- :Self, Wesley H. ;Tenforde, Mark W.9 24 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):Three COVID-19 vaccines are authorized or approved for use among adults in the United States (1,2). Two 2-dose mRNA vaccines, mRNA-1273 from Moderna a...
- :Tenforde, Mark W. ;Self, Wesley H.March 18, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):What is already known about this topic? COVID-19 mRNA vaccines provide protection against COVID-19 hospitalization among adults. However, how well mRN...
- :Tenforde, Mark W. ;Patel, Manish M.1 28 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):COVID-19 mRNA vaccines (BNT162b2 [Pfizer-BioNTech] and mRNA-1273 [Moderna]) provide protection against infection with SARS-CoV-2, the virus that cause...
- :Tenforde, Mark W. ;Self, Wesley H.3 25 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):COVID-19 mRNA vaccines (BNT162b2 [Pfizer-BioNTech] and mRNA-1273 [Moderna]) are effective at preventing COVID-19-associated hospitalization (1-3). How...
- :Surie, Diya ;Bonnell, Levi10 21 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):The SARS-CoV-2 Omicron variant (B.1.1.529 or BA.1) became predominant in the United States by late December 2021 (1). BA.1 has since been replaced by ...
- :Surie, Diya ;DeCuir, Jennifer12 30 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):Monovalent COVID-19 mRNA vaccines, designed against the ancestral strain of SARS-CoV-2, successfully reduced COVID-19-related morbidity and mortality ...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.